Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Fall on the Road
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Northwest Christmas
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fulgent Genetics Inc
(NQ:
FLGT
)
27.58
-0.05 (-0.18%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 30, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Fulgent Genetics Inc
< Previous
1
2
3
4
Next >
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 14, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting
November 03, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Reports Third Quarter 2023 Financial Results
November 03, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting
October 25, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023
October 17, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Reports Second Quarter 2023 Financial Results
August 04, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Exagen Inc. Appoints Paul Kim to Board of Directors
July 24, 2023
From
Exagen Inc.
Via
GlobeNewswire
Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023
July 18, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers
June 05, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual Meeting
May 18, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Reports First Quarter 2023 Financial Results
May 05, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023
April 20, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
February 28, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent to Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
February 23, 2023
From
Fulgent, Inc.
Via
Business Wire
Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
February 14, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
NASDAQ:FLGT Long Term Investor Alert: Investigation of Potential Wrongdoing at Fulgent Genetics, Inc.
February 09, 2023
San Diego, CA -- (SBWIRE) -- 02/09/2023 -- An investigation was announced for current long-term investors in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) concerning potential breaches of fiduciary...
Via
SBWire
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
January 13, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
January 10, 2023
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
Fulgent Expands Board of Directors with Addition of Reggie Groves
January 03, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
November 28, 2022
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
FLGT FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action - FLGT
November 19, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
November 18, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Fulgent Genetics to Participate in Piper Sandler’s 34th Annual Healthcare Conference
November 17, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm
November 16, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
FLGT DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors With Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - FLGT
November 16, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
NASDAQ:FLGT Investor Alert: Deadline on November 21, 2022 in Lawsuit Against Fulgent Genetics, Inc.
November 15, 2022
San Diego, CA -- (SBWIRE) -- 11/15/2022 -- The Shareholders Foundation announced that a deadline is coming up on November 21, 2022 in the lawsuit filed for certain investors of Fulgent Genetics, Inc....
Via
SBWire
Deadline Alert: Fulgent Genetics, Inc. (FLGT) - Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Class Action Deadlines and Encourages Shareholders to Contact the Firm and Actively Participate
November 15, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT
November 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm
November 11, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.